7/30/2013 1:30:34 PM - Encountering distributional pressure today, pulling back from its 52-week high after an impressive spurt of volume-driven gains. Reported earnings <strong>-5%</strong> on <strong>+2%</strong> sales for the Jun &#39;13 quarter. Noted in prior mid-day reports with caution - <em>&quot;Quarterly earnings increases through Mar &#39;13 have been persistently below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;.&quot;</em><br><hr>7/24/2013 2:05:23 PM - Perched at its 52-week high after an impressive spurt of volume-driven gains. Noted in prior mid-day reports with caution - <em>&quot;Quarterly earnings increases through Mar &#39;13 have been persistently below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;.&quot;</em><br><hr>7/23/2013 1:04:23 PM - Perched at its 52-week high, adding to a spurt of volume-driven gains. Last noted in the 7/18/13 mid-day report with caution - <em>&quot;Quarterly earnings increases through Mar &#39;13 have been persistently below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;.&quot;</em><br><hr>7/18/2013 1:26:23 PM - Touched a new 52-week high today then reversed into the red. Rallied from support at its 50 DMA line with a spurt of volume-driven gains since last noted in the 6/24/13 mid-day report with caution. Quarterly earnings increases through Mar &#39;13 have been persistently below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &quot;How To Make Money In Stocks&quot;.<br><hr>6/24/2013 12:47:28 PM - Consolidating near its 50 DMA line. Reported earnings <strong>-5%</strong> on <strong>+1%</strong> sales for the Mar &#39;13 quarter. Found support above its 200 DMA line during its consolidation since last noted in the 3/12/13 mid-day report with caution - <em>&quot;Reported earnings <strong>+11%</strong> on <strong>+4%</strong> sales revenues for the Dec &#39;12 quarter. Found prompt support after recently violating its 50 DMA line. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>9</strong> quarterly earnings comparisons through Sep &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>3/12/2013 12:57:47 PM - Retreating from its 52-week high hit last week while it tallied <strong>4 </strong>consecutive volume-driven gains. Prior mid-day reports repeatedly cautioned members - <em>&quot;Reported earnings <strong>+11%</strong> on <strong>+4%</strong> sales revenues for the Dec &#39;12 quarter. Found prompt support after recently violating its 50 DMA line. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>9</strong> quarterly earnings comparisons through Sep &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>3/8/2013 12:53:00 PM - Perched at its 52-week highs today while tallying a <strong>4</strong>th consecutive volume-driven gain. Prior mid-day reports repeatedly cautioned members - <em>&quot;Reported earnings <strong>+11%</strong> on <strong>+4%</strong> sales revenues for the Dec &#39;12 quarter. Found prompt support after recently violating its 50 DMA line. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>9</strong> quarterly earnings comparisons through Sep &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>3/7/2013 12:57:23 PM - Powering to new 52-week highs today with a <strong>3</strong>rd consecutive volume-driven gain. Reported earnings <strong>+11%</strong> on <strong>+4%</strong> sales revenues for the Dec &#39;12 quarter. Found prompt support after recently violating its 50 DMA line. Prior mid-day reports cautioned - <em>&quot;Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>9</strong> quarterly earnings comparisons through Sep &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>3/5/2013 1:28:30 PM - Perched at its 52-week high today with a small volume-driven gain. Reported earnings <strong>+11%</strong> on <strong>+4%</strong> sales revenues for the Dec &#39;12 quarter. Found prompt support after recently violating its 50 DMA line. Prior mid-day reports cautioned - <em>&quot;Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>9</strong> quarterly earnings comparisons through Sep &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>1/18/2013 12:46:22 PM - Rallying near its 52-week high today while adding to a spurt of volume-driven gains. Found prompt support after recently violating its 50 DMA line. Prior mid-day reports cautioned - <em>&quot;Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>9</strong> quarterly earnings comparisons through Sep &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>12/27/2012 12:29:43 PM - Violating its 50 DMA line and slumping under prior highs with a damaging loss today. It has been slumping due to distributional pressure since last noted in the 12/06/12 mid-day report - <em>&quot;Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>9</strong> quarterly earnings comparisons through Sep &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>12/6/2012 12:26:06 PM - Holding its ground near its 52-week high today following a streak of <strong>8</strong> consecutive gains capped by a big volume-driven gain on the prior session. Found support in recent months when trading near its 50 DMA line. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &quot;How To Make Money In Stocks&quot;. The past <strong>9</strong> quarterly earnings comparisons through Sep &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.<br><hr>10/16/2012 12:52:54 PM - Hovering near its 52-week high today, still holding its ground stubbornly after a spurt of volume-driven gains. Due to report earnings on the morning of Thursday, October 18th. Found support in recent months when trading near its 50 DMA line. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &quot;How To Make Money In Stocks&quot;. The past <strong>9</strong> quarterly earnings comparisons through Jun &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.<br><hr>10/11/2012 12:55:11 PM - Perched at its 52-week high today, still holding its ground stubbornly after a spurt of volume-driven gains. Found support in recent months when trading near its 50 DMA line. Reported earnings <strong>+12%</strong> on <strong>+7%</strong> sales revenues for the quarter ended June 30, 2012 versus the year ago period. Prior mid-day reports repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>10/9/2012 12:52:48 PM - Perched at its 52-week high today, holding its ground stubbornly after a spurt of volume-driven gains. Found support in recent months when trading near its 50 DMA line. Reported earnings <strong>+12%</strong> on <strong>+7%</strong> sales revenues for the quarter ended June 30, 2012 versus the year ago period. Prior mid-day reports repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>10/8/2012 12:26:30 PM - Hit another new 52-week high today. Held its ground stubbornly after a streak of <strong>6</strong> consecutive volume-driven gains. Found support in recent months when trading near its 50 DMA line. Reported earnings <strong>+12%</strong> on <strong>+7%</strong> sales revenues for the quarter ended June 30, 2012 versus the year ago period. Prior mid-day reports repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>10/5/2012 12:46:11 PM - Perched at its 52-week high today, holding its ground after a streak of <strong>6</strong> consecutive volume-driven gains. Found support in recent months when trading near its 50 DMA line. Reported earnings <strong>+12%</strong> on <strong>+7%</strong> sales revenues for the quarter ended June 30, 2012 versus the year ago period. Prior mid-day reports repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>10/4/2012 12:31:46 PM - Perched at its 52-week high today following <strong>6</strong> consecutive volume-driven gains. Found support in recent months when trading near its 50 DMA line. Reported earnings <strong>+12%</strong> on <strong>+7%</strong> sales revenues for the quarter ended June 30, 2012 versus the year ago period. Prior mid-day reports repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>10/3/2012 12:52:46 PM - Spiking to new 52-week highs and on track today for its <strong>6</strong>th consecutive volume-driven gain. Found support in recent months when trading near its 50 DMA line. Reported earnings <strong>+12%</strong> on <strong>+7%</strong> sales revenues for the quarter ended June 30, 2012 versus the year ago period. Prior mid-day reports repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>10/2/2012 12:37:48 PM - Spiking to new 52-week highs this week with volume-driven gains. Found support in recent months when trading near its 50 DMA line. Reported earnings <strong>+12%</strong> on <strong>+7%</strong> sales revenues for the quarter ended June 30, 2012 versus the year ago period. Prior mid-day reports repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>8/31/2012 12:36:18 PM - Still hovering just <strong>-4.4%</strong> off its 52-week high today and consolidating near its 50 DMA line. Reported earnings <strong>+12%</strong> on <strong>+7%</strong> sales revenues for the quarter ended June 30, 2012 versus the year ago period. Prior mid-day reports repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>8/3/2012 12:44:46 PM - Still hovering near its 52-week high today. Reported earnings <strong>+12%</strong> on <strong>+7%</strong> sales revenues for the quarter ended June 30, 2012 versus the year ago period. Volume totals have been cooling after a recent spurt of gains with above average volume helped it make progress above its prior highs. Held its ground stubbornly while several mid-day reports since May repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>7/25/2012 1:05:33 PM - Still hovering near its 52-week high today. Reported earnings <strong>+12%</strong> on <strong>+7%</strong> sales revenues for the quarter ended June 30, 2012 versus the year ago period. Volume totals have been cooling after a recent spurt of gains with above average volume helped it make progress above its prior highs. Held its ground stubbornly while several mid-day reports since May repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>7/16/2012 12:41:22 PM - Perched at its 52-week high today. Recent spurt of gains with above average volume helped it make progress above its prior highs. Held its ground stubbornly while several mid-day reports since May repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>7/13/2012 12:42:01 PM - Trading up again today, rallying further into new 52-week high territory. Recent spurt of gains with above average volume helped it make progress above its prior highs. Held its ground stubbornly while several mid-day reports since May repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>7/12/2012 12:53:45 PM - Trading up again today after a negative reversal on the prior session at its 52-week high. Recent spurt of gains with above average volume helped it make progress above its prior highs. Held its ground stubbornly while several mid-day reports since May repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>7/11/2012 12:15:57 PM - Hitting another new 52-week high today, adding to its recent spurt of gains with above average volume and making more progress above its prior highs this week. Held its ground stubbornly while several mid-day reports since May repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>7/10/2012 12:40:46 PM - Inching to a new 52-week high today. Made limited progress yet held its ground stubbornly while several mid-day reports since May repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>7/5/2012 12:48:44 PM - Made limited progress yet held its ground stubbornly while several mid-day reports since May repeatedly noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>7/2/2012 12:55:19 PM - Still churning higher than average volume at its 52-week high without making very meaningful price progress, previously noted as a sign of distributional pressure after building a base-on-base pattern. Prior mid-day reports noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Repeatedly noted in prior mid-day reports - &#39;Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&#39;&quot; </em><br><hr>6/27/2012 1:12:08 PM - Still churning heavy volume at its 52-week high without making meaningful price progress, previously noted as a sign of distributional pressure after building a base-on-base pattern. Prior mid-day reports noted -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Repeatedly noted in prior mid-day reports - &#39;Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&#39;&quot; </em><br><hr>6/26/2012 1:04:54 PM - Churning heavy volume at its 52-week high without making meaningful price progress is a sign it recently has been encountering distributional pressure after building a base-on-base pattern. Last noted in the 6/20/12 mid-day report -<em> &quot;Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Repeatedly noted in prior mid-day reports - &#39;Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&#39;&quot; </em><br><hr>6/20/2012 12:36:51 PM - Touched a new 52-week high today while building on a base-on-base pattern, consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Repeatedly noted in prior mid-day reports - <em>&quot;Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>5/24/2012 12:34:06 PM - Still consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Repeatedly noted in prior mid-day reports - <em>&quot;Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>5/23/2012 12:49:13 PM - Still consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Noted in prior mid-day reports - <em>&quot;Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>5/21/2012 1:06:07 PM - Still consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Noted in prior mid-day reports - <em>&quot;Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>5/18/2012 12:47:52 PM - Consolidating above prior highs and its 50 DMA line in the <strong>$11</strong> area that define chart support. Last noted in the 4/25/12 mid-day report - <em>&quot;Low-priced stock is hitting a new 52-week high today. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &#39;How To Make Money In Stocks&#39;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.&quot; </em><br><hr>4/25/2012 1:37:29 PM - Low-priced stock is hitting a new 52-week high today. Annual earnings (<strong>A</strong> criteria) showed steady increases since a downturn in FY &#39;08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, &quot;How To Make Money In Stocks&quot;. The past <strong>8</strong> quarterly earnings comparisons through Mar &#39;12 were below the <strong>+25%</strong> minimum guideline of the fact-based investment system.<br><hr>6/21/2010 12:42:05 PM - Low-priced stock is perched near its 52-week high after recently finding support near its 50 DMA line. Annual and quarterly earnings history has been below guidelines of the fact-based investment system.<br><hr>